Marrow Access Technologies commenced full U.S. market release of the SmartShot marrow access device, designed specifically to address the needs of ankle joint preservation.
SmartShot uses a patented mechanism to create deep, microneedle channels into bone to stimulate the patient’s own natural healing reaction. Penetration of the outer layers of bone allows blood and stem cells from within the bone marrow to activate cartilage, ligament and tendon healing. In a recently published, independently funded and peer-reviewed animal study, researchers at the University of Pennsylvania concluded that SmartShot best preserved the underlying subchondral bone compared to traditional marrow access approaches.
SmartShot is commercially available in the United States with rapidly expanding distribution.
The platform SmartShot marrow access device is indicated for treatment of injuries in the knee, hip, shoulder, ankle, wrist and elbow and has been used successfully in more than 1,000 patients.
Marrow Access Technologies commenced full U.S. market release of the SmartShot marrow access device, designed specifically to address the needs of ankle joint preservation.
SmartShot uses a patented mechanism to create deep, microneedle channels into bone to stimulate the patient’s own natural healing reaction. Penetration of the outer layers...
Marrow Access Technologies commenced full U.S. market release of the SmartShot marrow access device, designed specifically to address the needs of ankle joint preservation.
SmartShot uses a patented mechanism to create deep, microneedle channels into bone to stimulate the patient’s own natural healing reaction. Penetration of the outer layers of bone allows blood and stem cells from within the bone marrow to activate cartilage, ligament and tendon healing. In a recently published, independently funded and peer-reviewed animal study, researchers at the University of Pennsylvania concluded that SmartShot best preserved the underlying subchondral bone compared to traditional marrow access approaches.
SmartShot is commercially available in the United States with rapidly expanding distribution.
The platform SmartShot marrow access device is indicated for treatment of injuries in the knee, hip, shoulder, ankle, wrist and elbow and has been used successfully in more than 1,000 patients.
Copy to clipboard 
